vs
Side-by-side financial comparison of Amarin Corp plc (AMRN) and FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ). Click either name above to swap in a different company.
Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $44.3M, roughly 1.0× FIRST BUSINESS FINANCIAL SERVICES, INC.). FIRST BUSINESS FINANCIAL SERVICES, INC. runs the higher net margin — 27.5% vs -23.3%, a 50.8% gap on every dollar of revenue. On growth, FIRST BUSINESS FINANCIAL SERVICES, INC. posted the faster year-over-year revenue change (8.5% vs 7.0%). Over the past eight quarters, FIRST BUSINESS FINANCIAL SERVICES, INC.'s revenue compounded faster (8.0% CAGR vs -18.3%).
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.
The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.
AMRN vs FBIZ — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $45.1M | $44.3M |
| Net Profit | $-10.5M | $12.2M |
| Gross Margin | — | — |
| Operating Margin | 35.5% | — |
| Net Margin | -23.3% | 27.5% |
| Revenue YoY | 7.0% | 8.5% |
| Net Profit YoY | 33.0% | 9.2% |
| EPS (diluted) | — | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $45.1M | $44.3M | ||
| Q4 25 | $49.2M | $42.2M | ||
| Q3 25 | $49.7M | $44.5M | ||
| Q2 25 | $72.7M | $41.0M | ||
| Q1 25 | $42.0M | $40.8M | ||
| Q4 24 | $62.3M | $41.2M | ||
| Q3 24 | $42.3M | $38.1M | ||
| Q2 24 | $67.5M | $38.0M |
| Q1 26 | $-10.5M | $12.2M | ||
| Q4 25 | $-1.2M | $13.3M | ||
| Q3 25 | $-7.7M | $14.4M | ||
| Q2 25 | $-14.1M | $11.4M | ||
| Q1 25 | $-15.7M | $11.2M | ||
| Q4 24 | $-48.6M | $14.4M | ||
| Q3 24 | $-25.1M | $10.5M | ||
| Q2 24 | $1.5M | $10.5M |
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 38.5% | ||
| Q3 25 | -22.4% | 39.0% | ||
| Q2 25 | -22.0% | 32.6% | ||
| Q1 25 | -39.9% | 33.0% | ||
| Q4 24 | -84.3% | 37.2% | ||
| Q3 24 | -59.5% | 33.8% | ||
| Q2 24 | -0.8% | 32.6% |
| Q1 26 | -23.3% | 27.5% | ||
| Q4 25 | -2.5% | 31.6% | ||
| Q3 25 | -15.6% | 32.3% | ||
| Q2 25 | -19.4% | 27.8% | ||
| Q1 25 | -37.4% | 27.4% | ||
| Q4 24 | -78.0% | 35.0% | ||
| Q3 24 | -59.4% | 27.6% | ||
| Q2 24 | 2.3% | 27.5% |
| Q1 26 | — | $1.44 | ||
| Q4 25 | $0.00 | $1.57 | ||
| Q3 25 | $-0.02 | $1.70 | ||
| Q2 25 | $-0.03 | $1.35 | ||
| Q1 25 | $-0.04 | $1.32 | ||
| Q4 24 | $-0.12 | $1.69 | ||
| Q3 24 | $-0.06 | $1.24 | ||
| Q2 24 | $0.00 | $1.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $307.8M | $265.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $645.8M | $4.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $307.8M | $265.8M | ||
| Q4 25 | $302.6M | $39.5M | ||
| Q3 25 | $286.6M | $44.3M | ||
| Q2 25 | $298.7M | $123.2M | ||
| Q1 25 | $281.8M | $170.6M | ||
| Q4 24 | $294.2M | $157.7M | ||
| Q3 24 | $305.7M | $132.0M | ||
| Q2 24 | $306.7M | $81.1M |
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $371.6M | ||
| Q3 25 | $458.9M | $358.3M | ||
| Q2 25 | $464.9M | $344.8M | ||
| Q1 25 | $473.7M | $336.1M | ||
| Q4 24 | $486.2M | $328.6M | ||
| Q3 24 | $531.4M | $312.0M | ||
| Q2 24 | $551.9M | $305.2M |
| Q1 26 | $645.8M | $4.3B | ||
| Q4 25 | $670.8M | $4.1B | ||
| Q3 25 | $659.8M | $4.0B | ||
| Q2 25 | $670.1M | $4.0B | ||
| Q1 25 | $655.7M | $3.9B | ||
| Q4 24 | $685.3M | $3.9B | ||
| Q3 24 | $750.6M | $3.7B | ||
| Q2 24 | $799.9M | $3.9B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
FBIZ
Segment breakdown not available.
